Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P

Clinical trial NCT03369340 · COMPLETED

Trial details

NCT number: NCT03369340
Sponsor: Philip Morris Products S.A.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2017-11-07
Primary completion: 2018-02-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.